Immuron (IMRN) Current Taxes (2022 - 2023)
Immuron (IMRN) posted quarterly Current Taxes of $1028.7 for Q4 2023, down 86.22% year-on-year from $7462.9 in Q4 2022, and down 99.79% on a QoQ basis from $493082.5 in Q3 2023.
Immuron (IMRN) Current Taxes (2022 - 2023) Analysis & Trends
Immuron (IMRN) has reported Current Taxes for 2 consecutive years, with $1028.7 the latest figure, recorded in Q4 2023.
- Quarterly Current Taxes fell 86.22% year-over-year to $1028.7 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1028.7 (down 86.22% YoY) and the FY2023 annual result came in at $6982.0, down 6.44% from the prior year.
- Current Taxes declined to $1028.7 in Q4 2023 per IMRN's latest filing, from $493082.5 in the prior quarter.
- Over the last five years, Current Taxes for IMRN reached as high as $698195.0 in Q2 2023 and fell as low as $1028.7 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,028.71 |
| Sep 28, 2023 | 493,082.54 |
| Aug 30, 2023 | 6,981.95 |
| Jun 30, 2023 | 698,195.00 |
| Dec 31, 2022 | 7,462.88 |